Description of Collaborative Activity: |
Workshop participants will discuss the regulatory pathway for live biotherapeutics constituted of live microorganisms (such as bacteria or yeast) that may be naturally occurring, recombinant, or clonally selected; are applicable to the prevention, treatment, or cure of a disease or human condition; and are not an immunogen-specific vaccine. |
